Measuring indirect transmission-reducing effects in tuberculosis vaccine efficacy trials: why and how?

Overview of attention for article published in The Lancet Microbe, June 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 11 X users

Readers on

mendeley: 27 Mendeley

So far, Altmetric has seen 12 X posts from 11 X users, with an upper bound of 59,549 followers.

Open Access UCL Research: Measuring indirect transmission-reducing effects in tuberculosis vaccine efficacy trials: why and how? https://t.co/NKU4ZRd7pU

RT @EmoryEAVE: Measuring indirect transmission-reducing effects in tuberculosis vaccine efficacy trials can be crucial for policy makers de…

Measuring indirect transmission-reducing effects in tuberculosis vaccine efficacy trials can be crucial for policy makers deciding whether and how to introduce tuberculosis vaccines into immunization programmes. @kbratnelson @EmoryEPI @EmoryNews https:…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 8 additional X posts.